Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.

Neuropsychobiology - 1 Aug 2010

Lee Sang-Hyuk, Choi Tae Kyou, Lee Eun, Seok Jeong-Ho, Lee Sung Hee, Lee Hong Shick, Kim Se Joo

Abstract excerpt

BACKGROUND: Polymorphisms of serotonin transporter, especially serotonin transporter linked promoter region (5- HTTLPR) and serotonin transporter intron 2 variable number tandem repeat (5-HTTVNTR), have been suggested to be associated with treatment response to selective serotonin reuptake inhibitors. However, there have been only few reports of the association between 5-HTTLPR or 5-HTTVNTR and treatment response...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclohexanols
Share to Delayed-Action Preparations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Drug Administration Schedule

Share to Psychiatric Status Rating Scales

Share to Selective Serotonin Reuptake Inhibitors

Share to Serotonin Plasma Membrane Transport Proteins

Share to Venlafaxine Hydrochloride

Source

Identifiers

PMID: 20664233
DOI: 10.1159/000319362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.PMID 20664233Read ↗

SLC6A2 and SLC6A4 variants interact with venlafaxine serum concentrations to influence therapy outcome.Semantic proximity Read ↗

A Prospective Study of Serotonin and Norepinephrine Transporter Genes and the Response to Desvenlafaxine Over 8 Weeks in Major Depressive Disorder.Semantic proximity Read ↗

No Association Between SLC6A4 Gene Polymorphisms With Treatment Remission to Venlafaxine in Han Chinese Depressive Patients.Semantic proximity Read ↗

SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population.Semantic proximity Read ↗

Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.Semantic proximity Read ↗

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.Semantic proximity Read ↗

An observational study of Venlafaxine and CYP2D6 in clinical practice.Semantic proximity Read ↗

Serotonin transporter gene polymorphisms and sertraline response in major depression patients.Semantic proximity Read ↗

Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depressionSemantic proximity Read ↗

Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.Semantic proximity Read ↗

A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients.Semantic proximity Read ↗

Pharmacogenetics of selective serotonin reuptake inhibitors (SSRI): A serotonin reuptake transporter (SERT)-based approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.